Lack of value of the naproxen test in the differential diagnosis of prolonged febrile illnesses

American Journal of Medicine

Volumn 115, Issue 7, 2003, Pages 572-575

  Vanderschueren, Steven ^a   Knockaert, Daniël C ^a   Peetermans, Willy E ^a   Bobbaers, Herman J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; BODY TEMPERATURE; CHI SQUARE DISTRIBUTION; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DRUG EFFECT; FEMALE; GRANULOMATOSIS; HUMAN; INFECTION; INFLAMMATION; KIDNEY BIOPSY; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NONHODGKIN LYMPHOMA; PERIPHERAL EDEMA; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; STATISTICAL ANALYSIS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0242298312     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(03)00376-0     Document Type: Article

References (16)

1. Lusch C.J., Serpick A.A., Slater L. Antipyretic effect of indomethacin in patients with malignancy. Cancer. 21:1968;781-786.
2. Chang J.C., Gross H.M. Utility of naproxen in the differential diagnosis of fever of undetermined origin in patients with cancer. Am J Med. 76:1984;597-603.
3. Chang J.C. Antipyretic effect of naproxen and corticosteroids on neoplastic fever. J Pain Symptom Manage. 3:1988;141-144.
4. French J. Indomethacin therapy to control debilitating fever of unknown origin. Aust NZ J Med. 15:1985;270-271.
5. Azeemuddin S.K., Vega R.A., Kim T.H., Ragab A.H. The effect of naproxen of fever in children with malignancies. Cancer. 59:1987;1966-1968.
6. Economos K., Lucci J.A., Richardson B., Yazigi R., Miller D.S. The effect of naproxen on fever in patients with advanced gynecological malignancies. Gynecol Oncol. 56:1995;250-254.
7. Tsavaris N., Zinelis A., Karabelis A., et al. A randomized trial of three non-steroid anti-inflammatory agents in ameliorating cancer-induced fever. J Intern Med. 228:1990;451-455.
8. Plaisance K.I., Mackowiak P.A. Antipyretic therapy. Physiologic rationale, diagnostic implications, and clinical consequences. Arch Intern Med. 160:2000;449-456.
9. Arnow P.M., Flaherty J.P. Fever of unknown origin. Lancet. 350:1997;575-580.
10. Cunha B.A. Fever of unknown origin. Infect Dis Clin North Am. 10:1996;111-127.
11. Vanderschueren S., Knockaert D., Adriaenssens T., et al. From prolonged febrile illness to fever of unknown origin. The challenge continues. Arch Intern Med. 163:2003;1033-1041.
12. Petersdorf R.B., Beeson P.B. Fever of unexplained origin report on 100 cases . Medicine. 40:1961;1-30.
13. Durack D.T., Street A.C. Fever of unknown origin - reexamined and redefined. Curr Clin Top Infect Dis. 11:1991;35-51.
14. Bernard G., Wheeler A.P., Russell J.A., et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med. 336:1997;912-918.
15. Ohta A., Yamaguchi M., Kaneoka H., Nagayoshi T., Hiida M. Adult Still's disease review of 228 cases from the literature . J Rheumatol. 14:1987;1139-1146.
16. Pouchot J., Sampalis J.S., Beaudet F., et al. Adult Still's disease manifestations, disease course, and outcome in 62 patients. Medicine. 70:1991;118-136.